Sofosbuvir/Velpatasvir (SOF/VEL) with or without...

Gastroenterology 2017 / 04 Vol. 152; Iss. 5

Sofosbuvir/Velpatasvir (SOF/VEL) with or without Voxilaprevir (VOX) is Associated with Excellent Efficacy and Significant Improvements of Patient-Reported Outcomes (PROS) During Treatment and After Achieving Sustained Virologic Response (SVR)

Younossi, Zobair M., Stepanova, Maria, Jacobson, Ira M., Zeuzem, Stefan, Bourliere, Marc, Foster, Graham R., Roberts, Stuart, Asselah, Tarik, Thompson, Alexander, Gane, Edward, Willems, Bernard, Lawit
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(17)33586-2
Date:
April, 2017
File:
PDF, 472 KB
english, 2017
Conversion to is in progress
Conversion to is failed